Robert P. Numerof

2.1k total citations · 1 hit paper
33 papers, 1.7k citations indexed

About

Robert P. Numerof is a scholar working on Immunology, Genetics and Hematology. According to data from OpenAlex, Robert P. Numerof has authored 33 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 14 papers in Genetics and 13 papers in Hematology. Recurrent topics in Robert P. Numerof's work include Chronic Lymphocytic Leukemia Research (10 papers), Platelet Disorders and Treatments (9 papers) and Mast cells and histamine (7 papers). Robert P. Numerof is often cited by papers focused on Chronic Lymphocytic Leukemia Research (10 papers), Platelet Disorders and Treatments (9 papers) and Mast cells and histamine (7 papers). Robert P. Numerof collaborates with scholars based in United States, United Kingdom and Canada. Robert P. Numerof's co-authors include Jean‐Pierre Kinet, Marie‐Hélène Jouvin, Martin Adamczewski, Alain Vallé, Odile Letourneur, Albana Cumashi, Norman M. Schechter, Lawrence F. Brass, Marílyn J. Woolkalís and Mark Dreyer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Robert P. Numerof

30 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interactions of Mast Cell Tryptase with Thrombin Receptors and PAR-2

1997 506 citations Robert P. Numerof et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert P. Numerof United States	18	881	459	453	350	277	33	1.7k
Wenbin Xiao United States	24	635 0.7×	587 1.3×	483 1.1×	329 0.9×	92 0.3×	85	1.9k
Muriel Gaudry France	25	741 0.8×	909 2.0×	270 0.6×	163 0.5×	65 0.2×	36	1.9k
Akihiko Gotoh Japan	24	444 0.5×	644 1.4×	568 1.3×	306 0.9×	73 0.3×	121	1.8k
Olivier Harari United Kingdom	20	839 1.0×	428 0.9×	243 0.5×	135 0.4×	137 0.5×	37	1.9k
Christopher Ocampo United States	17	349 0.4×	929 2.0×	862 1.9×	288 0.8×	106 0.4×	33	2.2k
Christoph Renné Germany	20	738 0.8×	508 1.1×	314 0.7×	472 1.3×	52 0.2×	29	2.1k
Kaı̈ss Lassoued France	25	644 0.7×	575 1.3×	237 0.5×	242 0.7×	146 0.5×	64	1.9k
Mary J. Heeb United States	30	600 0.7×	475 1.0×	1.5k 3.3×	653 1.9×	113 0.4×	62	2.6k
T Matsuda Japan	7	1.2k 1.3×	668 1.5×	303 0.7×	124 0.4×	213 0.8×	9	2.4k
Renren Wen United States	31	1.7k 1.9×	873 1.9×	358 0.8×	158 0.5×	90 0.3×	75	2.8k

Countries citing papers authored by Robert P. Numerof

Since Specialization

Citations

This map shows the geographic impact of Robert P. Numerof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert P. Numerof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert P. Numerof more than expected).

Fields of papers citing papers by Robert P. Numerof

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert P. Numerof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert P. Numerof. The network helps show where Robert P. Numerof may publish in the future.

Co-authorship network of co-authors of Robert P. Numerof

This figure shows the co-authorship network connecting the top 25 collaborators of Robert P. Numerof. A scholar is included among the top collaborators of Robert P. Numerof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert P. Numerof. Robert P. Numerof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goel, Ruchika, et al.. (2024). Real-world experience with fostamatinib in patients with immune thrombocytopenia: Results of an observational study (FORTE).. Journal of Clinical Oncology. 42(16_suppl). e23289–e23289.

Kuter, David J., et al.. (2023). Fostamatinib for warm antibody autoimmune hemolytic anemia: Phase 3, randomized, double‐blind, placebo‐controlled, global study (FORWARD). American Journal of Hematology. 99(1). 79–87. 18 indexed citations

Hughes, David, et al.. (2021). An Observational Study of Fostamatinib As Second Line Therapy in Adult Patients with Immune Thrombocytopenia (ITP) in Real-World Clinical Practice. Blood. 138(Supplement 1). 4223–4223. 1 indexed citations

Tong, Sandra, et al.. (2020). Long-Term Safety Profile of the Oral Spleen Tyrosine Kinase Inhibitor Fostamatinib in Immune Thrombocytopenia (ITP) and Other Diseases. Blood. 136(Supplement 1). 35–36. 28 indexed citations

Altomare, Ivy, Vadim Markovtsov, Leslie Todd, et al.. (2019). Potential Anti-Thrombotic Effect without Accompanying Hemorrhage with Fostamatinib Use in Patients with Immune Thrombocytopenia. Blood. 134(Supplement_1). 4889–4889. 4 indexed citations

Rogers, Kerry A., Michael Boxer, Michael Y. Choi, et al.. (2019). Fostamatinib, a Spleen Tyrosine Kinase (SYK) Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (wAIHA): Final Results of the Phase 2, Multicenter, Open-Label Study. Blood. 134(Supplement_1). 3518–3518. 3 indexed citations

Négrier, Claude, et al.. (2016). Global Post-Authorization Safety Surveillance Study. Blood Coagulation & Fibrinolysis. 27(5). 551–556. 10 indexed citations

Lucas, Julie L., et al.. (2009). Induction of Foxp3+ regulatory T cells with histone deacetylase inhibitors. Cellular Immunology. 257(1-2). 97–104. 76 indexed citations

Numerof, Robert P. & Khusru Asadullah. (2006). Cytokine and Anti-Cytokine Therapies for Psoriasis and Atopic Dermatitis. BioDrugs. 20(2). 93–103. 65 indexed citations

10.

Numerof, Robert P., Charles A. Dinarello, & K. Asadullah. (2005). Cytokines as Potential Therapeutic Targets for Inflammatory Skin Diseases. PubMed. 16(2). 101–3. 19 indexed citations

11.

Elrod, Kyle, et al.. (1999). Expression and Characterization of Recombinant Mast Cell Tryptase. Protein Expression and Purification. 15(3). 251–257. 10 indexed citations

12.

Numerof, Robert P., Paul J. Simpson, & Richard D. Tanaka. (1997). Tryptase inhibitors: a novel class of anti-inflammatory drugs. Expert Opinion on Investigational Drugs. 6(7). 811–817. 2 indexed citations

13.

Zhang, Cheng, Andrew M. Scharenberg, Rossella Paolini, et al.. (1996). Syk-dependent Phosphorylation of Shc. Journal of Biological Chemistry. 271(27). 16268–16272. 108 indexed citations

14.

Paolini, Rossella, et al.. (1996). IgE receptor (Fc epsilon RI) and signal transduction.. PubMed. 22. 116s–118s. 10 indexed citations

15.

Jouvin, Marie‐Hélène, Robert P. Numerof, & Jean‐Pierre Kinet. (1995). Signal transduction through the conserved motifs of the high affinity IgE receptor FcεRI. Seminars in Immunology. 7(1). 29–35. 46 indexed citations

16.

Jouvin, Marie‐Hélène, Martin Adamczewski, Robert P. Numerof, et al.. (1994). Differential control of the tyrosine kinases Lyn and Syk by the two signaling chains of the high affinity immunoglobulin E receptor.. Journal of Biological Chemistry. 269(8). 5918–5925. 311 indexed citations

17.

Paolini, Rossella, Robert P. Numerof, & Jean-Pierre Kinet. (1994). Kinase Activation through the High-Affinity Receptor for Immunoglobulin E. PubMed. 4(1). 35–40. 10 indexed citations

18.

Numerof, Robert P., Jean D. Sipe, Elizabeth Trehu, Charles A. Dinarello, & James W. Mier. (1992). Suppression of IL-2-induced SAA gene expression in mice by the administration of an IL-1 receptor antagonist. Cytokine. 4(6). 555–560. 7 indexed citations

19.

Numerof, Robert P., et al.. (1990). Pro-interleukin-1β production by a subpopulation of human T cells, but not NK cells, in response to interleukin-2. Cellular Immunology. 130(1). 118–128. 21 indexed citations

20.

Mier, James W., Frederick R. Aronson, Robert P. Numerof, Gloria Vachino, & Michael B. Atkins. (1988). Toxicity of Immunotherapy with Interleukin-2 and Lymphokine-Activated Killer Cells. Pathology and Immunopathology Research. 7(6). 459–476. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact